FDA Inspection
Angela D. Ritter, M.D.Angela D. Ritter, M.D. – FDA Inspection, Aug 17, 2023
Record Details
This FDA Inspection record concerns Angela D. Ritter, M.D., with an inspection on August 17, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 59a46f17-1e8a-4e51-bc69-56db11d31f3b
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1215162
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
FDA Citations
9- 21 CFR 56.104(c)Emergency use and IRB approval
- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.60Informed consent
- 21 CFR 312.56(c)Annual report
- 21 CFR 312.66Changes in research
- 21 CFR 312.56(c)Annual report
- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.66Changes in research
- 21 CFR 56.104(c)Emergency use and IRB approval
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.